📍Hyderabad, Telangana
IPO Pricing Valuation Reports for Hyderabad Companies
Independent Registered Valuer valuation report for IPO pricing — DCF and market comparables approach, Rule 11UA fair value computation for angel tax, SEBI ICDR compliant disclosure, and Ind AS 113 fair value measurement.
IPO Pricing Valuation Report — DCF, Comps & SEBI ICDR Rule 11UA in Hyderabad — Local Context
IPO pricing valuation requires a defensible view of forecasts, capital structure, comparable companies, cash flows, and market disclosures. Hyderabad businesses in technology, pharma, aerospace, and logistics may need assumptions that reflect recurring contracts, R&D cycles, export exposure, and capital-intensive operations.
Regulatory Office
SEBI (Securities and Exchange Board of India)
Provides the public-issue regulatory context for valuation disclosures and IPO pricing processes.
Typical Hyderabad Scenarios
- A T-Hub startup builds a DCF and comparable-company analysis for a proposed public issue.
- A Genome Valley pharma company evaluates pipeline investment and manufacturing capacity in its valuation assumptions.
- An aerospace supplier linked to ECIL reviews order-book visibility and working-capital needs for pricing analysis.
Who We Serve in Hyderabad
T-HubT-HubGenome Valley (pharma/biotech)ECIL (Electronics Corporation of India Limited)
Why Harun Raaj & Associates in Hyderabad
We are an ICAI-registered CA firm (Membership No. 238303) based in Visakhapatnam. Every output — certificate, return, or advisory — is reviewed and signed by a CA and carries a UDIN for authenticity. We handle the full regulatory workflow so your team doesn't have to — from document collection through filing or certification.
Looking for IPO Pricing Valuation Report — DCF, Comps & SEBI ICDR Rule 11UA outside Hyderabad? We serve clients across India.
View national service page →